165 related articles for article (PubMed ID: 8344844)
21. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx.
Parsons JT; Mendenhall WM; Mancuso AA; Cassisi NJ; Stringer SP; Million RR
Head Neck; 1989; 11(2):123-8. PubMed ID: 2722488
[TBL] [Abstract][Full Text] [Related]
22. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.
Ermiş E; Teo M; Dyker KE; Fosker C; Sen M; Prestwich RJ
Radiat Oncol; 2015 Sep; 10():203. PubMed ID: 26395876
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
[TBL] [Abstract][Full Text] [Related]
25. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer.
Narayana A; Vaughan AT; Kathuria S; Fisher SG; Walter SA; Reddy SP
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):21-6. PubMed ID: 10656367
[TBL] [Abstract][Full Text] [Related]
26. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy outcome and prognostic factors in early glottic carcinoma.
Raitiola H; Wigren T; Pukander J
Auris Nasus Larynx; 2000 Apr; 27(2):153-9. PubMed ID: 10733144
[TBL] [Abstract][Full Text] [Related]
28. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):727-32. PubMed ID: 17076093
[TBL] [Abstract][Full Text] [Related]
29. High daily fraction dose external radiotherapy for T1 glottic carcinoma: treatment results and prognostic factors.
Gultekin M; Ozyar E; Cengiz M; Ozyigit G; Hayran M; Hosal S; Akyol F
Head Neck; 2012 Jul; 34(7):1009-14. PubMed ID: 22052787
[TBL] [Abstract][Full Text] [Related]
30. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.
Mucha-Małecka A; Chrostowska A; Urbanek K; Małecki K
Strahlenther Onkol; 2019 Sep; 195(9):792-804. PubMed ID: 31214734
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx.
Fein DA; Lee WR; Hanlon AL; Ridge JA; Langer CJ; Curran WJ; Coia LR
J Clin Oncol; 1995 Aug; 13(8):2077-83. PubMed ID: 7636551
[TBL] [Abstract][Full Text] [Related]
33. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy.
Foote RL; Olsen KD; Kunselman SJ; Schaid DJ; Buskirk SJ; Grado GL; Earle JD
Mayo Clin Proc; 1992 Jul; 67(7):629-36. PubMed ID: 1434895
[TBL] [Abstract][Full Text] [Related]
34. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):823-31. PubMed ID: 8598359
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
36. Early glottic carcinoma involving the anterior commissure.
Shvero J; Hadar T; Segal K; Levy R; Feinmesser R
Clin Otolaryngol Allied Sci; 1994 Apr; 19(2):105-8. PubMed ID: 8026085
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.
Lim YJ; Wu HG; Kwon TK; Hah JH; Sung MW; Kim KH; Park CI
Cancer Res Treat; 2015 Oct; 47(4):862-70. PubMed ID: 25687859
[TBL] [Abstract][Full Text] [Related]
38. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
39. Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables.
Small W; Mittal BB; Brand WN; Shetty RM; Rademaker AW; Beck GG; Hoover SV
Radiology; 1992 Jun; 183(3):789-94. PubMed ID: 1584935
[TBL] [Abstract][Full Text] [Related]
40. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]